Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015)
Bausch Health Companies' (BHC) quarterly Current Deferred Tax Assets came in at $727.2 million in Q3 2015, up 129.84% year-on-year from $316.4 million in Q3 2014, and up 2.22% quarter-over-quarter from $711.4 million in Q2 2015.
Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Bausch Health Companies has disclosed Current Deferred Tax Assets across 6 years of filings, most recently posting $727.2 million for Q3 2015.
- Current Deferred Tax Assets for Q3 2015 came in at $727.2 million, up 129.84% year-over-year; the trailing twelve-month figure through Sep 2015 was $727.2 million (up 129.84% YoY), and the FY2014 annual result was $193.3 million, down 47.32% from the prior year.
- Current Deferred Tax Assets came in at $727.2 million for Q3 2015 at Bausch Health Companies, up from $711.4 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $727.2 million in Q3 2015 to a low of $77.5 million in Q3 2011.
- The 5-year median for Current Deferred Tax Assets is $196.5 million (2015), against an average of $252.5 million.
- Across the five-year window, Current Deferred Tax Assets jumped 540.48% in 2011 and slumped 47.32% in 2014, its largest moves.
- Bausch Health Companies' Current Deferred Tax Assets stood at $148.5 million in 2011, then soared by 31.36% to $195.0 million in 2012, then jumped by 88.15% to $366.9 million in 2013, then slumped by 47.32% to $193.3 million in 2014, then jumped by 276.2% to $727.2 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $727.2 million (Q3 2015), $711.4 million (Q2 2015), and $196.5 million (Q1 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 727.20 Mn |
| Sep 30, 2015 | 727.20 Mn |
| Jun 30, 2015 | 711.40 Mn |
| Jun 30, 2015 | 711.40 Mn |
| Mar 31, 2015 | 196.50 Mn |
| Mar 31, 2015 | 196.50 Mn |
| Dec 31, 2014 | 193.30 Mn |
| Dec 31, 2014 | 193.30 Mn |
| Sep 30, 2014 | 316.40 Mn |
| Sep 30, 2014 | 316.40 Mn |
| Jun 30, 2014 | 309.80 Mn |
| Jun 30, 2014 | 309.80 Mn |
| Mar 31, 2014 | 315.30 Mn |
| Mar 31, 2014 | 315.30 Mn |
| Dec 31, 2013 | 366.90 Mn |
| Dec 31, 2013 | 366.90 Mn |
| Sep 30, 2013 | 221.93 Mn |
| Sep 30, 2013 | 221.93 Mn |
| Jun 30, 2013 | 198.67 Mn |
| Jun 30, 2013 | 198.67 Mn |